Recruiting
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
ClinicalTrials.gov IDNCT07155707
PhaseNA
Enrollment156
SponsorStanford University
Age5 Years – 14 Years
SexALL
Conditions studied
Anxiety, Mood Disorders
About this study
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Interventions
- Other: Teleo — Therapist-led psychotherapy sessions implemented within the Teleo virtual therapy platform.
- Other: Standard Videoconferencing — Therapist-led psychotherapy sessions implemented in standard (non-Teleo) video platform.
Primary outcomes
- Child Involvement Rating Scale (CIRS) (Week 1)
Eligibility information
Inclusion Criteria:
* Diagnosed with a mood and/or anxiety disorder
* Have proficiency to participate in psychotherapy in English
* Scheduled to begin therapy at one of the study sites
* RCADS score \> 65
Exclusion Criteria:
\- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Study locations
- Ohana Center for Child and Adolescent Behavioral Health, Monterey, California 93940 United States
- Stanford University, Stanford, California 94305 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-13.